PlainPharmaWatch

CMS Open Payments · Program Year 2024

Lucid Diagnostics Inc.

Lucid Diagnostics Inc. reported $393,956.66 in payments to 1,603 physicians and teaching hospitals across 1,642 transactions.

$394.0K
Total payments
1,642
Transactions
1,603
Recipients
+$66.4K
General Payments vs PY2023

Lucid Diagnostics Inc. reported $393,956.66 in payments to 1,603 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #826 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $245.76 per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

The verdict

Lucid Diagnostics Inc. pairs above-median payment volume with a moderately concentrated payment pattern.

#826
of 1,925 companies
0.0%
of all US industry payments
0.4%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Lucid Diagnostics Inc.'s CMS-reported General Payments increased by $66.4K (+48.5%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: LUCID DIAGNOSTICS INC.PY2023: LUCID DIAGNOSTICS INC.PY2024: Lucid Diagnostics Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$136.9KPY2024$203.3K
PY2023
$136,930.64
PY2024
$203,334.46

How Lucid Diagnostics Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Lucid Diagnostics Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$393,957 Top 43% higher than 57% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Lucid Diagnostics Inc.

Lucid Diagnostics Inc. ranks #826 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $393,956.66 across 1,642 transactions to 1,603 physicians and teaching hospitals - $239.92 per transaction and $245.76 per recipient on average.

52 transactions worth $148.2K make "Consulting Fee" the top general-payment category in the 4-category breakdown below, 37.6% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Consulting Fee" leads Lucid Diagnostics Inc.'s 4-category general-payment breakdown at $148.2K, 37.6% of the reported total.

How Lucid Diagnostics Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$148.2K2. Food and Beverage$42.6K3. Compensation for Services…$7.5K4. Travel and Lodging$5.0K
Payment Type Amount Transactions
Consulting Fee $148.2K 52
Food and Beverage $42.6K 1,522
Compensation for Services Other Than Consulting $7.5K 23
Travel and Lodging $5.0K 6

Recipient Concentration in General Payments

The five largest recipient relationships account for $128,980.44 (63.4%) of $203,334.46 in this company's General Payments records across 958 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Lucid Diagnostics Inc.

The five named recipients with the highest reported General Payments from this company

Alfred Lui$72.8KJess Savala$22.5KSeper Dezfoli$17.4KRichard Gomez$9.2KSanford Markowitz$7.1K
  1. 1

    Alfred Lui

    $72,797.20 across 12 reported transactions

  2. 2

    Jess Savala

    $22,502.42 across 10 reported transactions

  3. 3

    Seper Dezfoli

    $17,419.33 across 22 reported transactions

  4. 4

    Richard Gomez

    $9,186.49 across 2 reported transactions

  5. 5

    Sanford Markowitz

    $7,075.00 across 5 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $239.92. Average per recipient: $245.76.

Total Amount

$393,956.66

Avg per Transaction

$239.92

Avg per Recipient

$245.76

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Lucid Diagnostics Inc. Share

0.0%

#826 by total payments

Frequently Asked Questions

How much did Lucid Diagnostics Inc. pay to physicians and hospitals in 2024?
In Program Year 2024, CMS Open Payments recorded $393,956.66 from Lucid Diagnostics Inc. to physicians and hospitals across 1,642 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Lucid Diagnostics Inc.?
1,603 physicians and teaching hospitals received payments from Lucid Diagnostics Inc. in 2024, averaging $245.76 per recipient.
What types of payments did Lucid Diagnostics Inc. make?
4 categories of general payment make up Lucid Diagnostics Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $148.2K, representing 37.6% of the company's reported total.
How does Lucid Diagnostics Inc. rank among pharmaceutical companies?
Out of 1,925 companies in the CMS Open Payments database for 2024, Lucid Diagnostics Inc. ranks #826 by total payment amount.
What is the average payment size from Lucid Diagnostics Inc.?
In 2024, Lucid Diagnostics Inc. averaged $239.92 per transaction across 1,642 transactions to 1,603 recipients.
Where does the payment data for Lucid Diagnostics Inc. come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Lucid Diagnostics Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.